Aker Biomarine ASA
OSE:AKBM
Aker Biomarine ASA
Revenue
Aker Biomarine ASA
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Aker Biomarine ASA
OSE:AKBM
|
Revenue
$198.9m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Orkla ASA
OSE:ORK
|
Revenue
kr70.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Leroy Seafood Group ASA
OSE:LSG
|
Revenue
kr31.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
SalMar ASA
OSE:SALM
|
Revenue
kr26.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
17%
|
CAGR 10-Years
14%
|
|
|
Austevoll Seafood ASA
OSE:AUSS
|
Revenue
kr35.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Mowi ASA
OSE:MOWI
|
Revenue
€5.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Aker Biomarine ASA
Glance View
Aker BioMarine AS operates as a biotech innovator and Antarctic krill-harvesting company which develops krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company is headquartered in Lysaker, Akershus. The company went IPO on 2020-07-06. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.
See Also
What is Aker Biomarine ASA's Revenue?
Revenue
198.9m
USD
Based on the financial report for Dec 31, 2024, Aker Biomarine ASA's Revenue amounts to 198.9m USD.
What is Aker Biomarine ASA's Revenue growth rate?
Revenue CAGR 5Y
-4%
Over the last year, the Revenue growth was -41%. The average annual Revenue growth rates for Aker Biomarine ASA have been -9% over the past three years , -4% over the past five years .
You don't have any saved screeners yet